Treasure Coast Sun

WASHINGTON, D.C. — Rep. Brian Mast (FL-21), co-chairmen of the bipartisan Congressional Cannabis Caucus, commended the Drug Enforcement Administration's recent decision to reschedule cannabis from Schedule I to Schedule III under the Controlled Substances Act.

"This is an important step, but more needs to be done," stated Rep. Mast, emphasizing the significance of this shift in policy. He highlighted the potential benefits of rescheduling cannabis, noting, "Today’s decision breaks a nearly 80-year stalemate in regards to cannabis, opening the door for it to be used for medicinal and research purposes. Rescheduling means cannabis will be an option for veterans and adults living with chronic diseases, including epilepsy, multiple sclerosis, and opioid use disorder."

Rep. Mast also drew attention to the societal impact of cannabis-related offenses, stating, "Millions of Americans have had opportunities for stable housing and employment foreclosed due to petty and non-violent cannabis-related offenses, including in jurisdictions that have since legalized the substance." He further pointed out the challenges in accessing medicinal cannabis, particularly for patients in need, including veterans.

In response to these developments, Rep. Mast emphasized the need for a comprehensive regulatory framework that balances the protection of children with enabling safe growth, manufacturing, prescription, sale, and consumption of cannabis by adults. Looking ahead, he expressed readiness to collaborate with relevant agencies to address these issues, stating, "We look forward to working with the agencies on this issue in the coming months."